AzTrials
AzTrials

HealthyNEUROMODNCT03167931

Neuromodulation by Non-invasive Brain Stimulation

A study testing MRI + transcranial Magnetic Stimulation and transcranial electric stimulation + electroencephalogram in people with Healthy and Transcranial Magnetic Stimulation, run by University Hospital, Grenoble at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The main objective of this study is to estimate the effect of the neuromodulation on the behavioral performances during the access in semantics according to the age of the individuals. Read more about this study

Who is it for?
Ages 18 to 85 yearsHealthy volunteers can take part
What is being tested?
MRI + transcranial Magnetic Stimulation and transcranial electric stimulation + electroencephalogram
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 siteFrance
Study dates
31 Aug 2017to Jun 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Major healthy Subject ( 18 - 85 years)
  • Right-hander
  • Signed Informed consent
  • A medical examination must be made before the participation for the research
  • Membership in or beneficiary of a national insurance scheme
  • Non inclusion Criteria:
Show all 16Show fewer
  • Subject under age 18 and of more than 85 years.
  • Contraindications in the practice of MRI, TMS and tES
  • Existence of a severe affection on the general plan: cardiac, respiratory, hematological, renal, hepatic, cancerous
  • Regular taking of anxiolytic, sedative, antidepressant, neuroleptic
  • Characterized psychiatric pathology
  • Ingestion of alcohol before the examination
  • Pregnancy, parturiency or breast-feeding
  • Private person of freedom by court or administrative order, nobody being the object of a legal protective measure (under guardianship or guardianship)
  • Participation to other protocols of current search with period of exclusion or in the previous week
  • Subject which would perceive more than 4500 euros of compensation because of its participation in other searches involving the human person in 12 months preceding this study.

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

France1 site, 1 recruiting
  • CHU

    Grenoble, 38043

    Thierry BOUGEROL, TBougerol@chu-grenoble.fr

    Laurent TORLAY, laurent.torlay@univ-grenoble-alpes.fr

    Recruiting

Other trials in France

About this study

Official title: Neuromodulation by Non-invasive Brain Stimulation (NEUROMOD)

The main objective of this study is to estimate the effect of the neuromodulation on the behavioral performances during the access in semantics according to the age of the individuals.

Neuromodulation by non-invasive stimulation allows to explore the functioning of the brain by exciting or by inhibiting localized cortical zones. The modulation of the performances in cognitive tasks, further to the neuromodulation of these zones, allows to deduce on their functional roles.

Read the detailed description

The objective of this project is to determine the changes of behavioral performances (time of answer, percentage of correct answers) further to the neuromodulation. The specific question is to estimate the effect on the performances of access at the semantic representations of this method, according to the age. One of the hypotheses in the research on the normal ageing is the difficulty of access to these representations (fundamental process for the cognitive functions, such as the language and the memory) at the healthy elderly. By using the neuromodulation the investigators wish to explore this hypothesis and to understand if the neuromodulation can have a beneficial effect on the improvement of the behavioral performances of the elderly.

Being tested
MRI + transcranial Magnetic Stimulation, transcranial electric stimulation + electroencephalogram
Keywords
non-invasive brain stimulation, neuromodulation, semantic tasks

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MRI + transcranial Magnetic StimulationOther

    Healthy subjects undergo 2 sessions of MRI + transcranial Magnetic Stimulation + transcranial electric stimulation + electroencephalogram. The 2 sessions are performed with an interval of 3 to 7 days.

  • transcranial electric stimulation + electroencephalogramOther

    Healthy subjects undergo 2 sessions of MRI + transcranial Magnetic Stimulation + transcranial electric stimulation + electroencephalogram. The 2 sessions are performed with an interval of 3 to 7 days.

Study groups in NCT03167931
Study groupRoleWhat they receive
18-49 years groupExperimentalParticipants undergo 2 sessions of MRI + transcranial Magnetic Stimulation or transcranial electric stimulation + electroencephalogram. The 2 sessions are performed with an interval of 3 to 7 days.
Receives: Other: MRI + transcranial Magnetic Stimulation; Other: transcranial electric stimulation + electroencephalogram
50-85 years groupExperimentalParticipants undergo 2 sessions of MRI + transcranial Magnetic Stimulation or transcranial electric stimulation + electroencephalogram. The 2 sessions are performed with an interval of 3 to 7 days.
Receives: Other: MRI + transcranial Magnetic Stimulation; Other: transcranial electric stimulation + electroencephalogram

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Effect of the neuromodulation on the behavioral performances during the access in semantics

    Evaluation of the changes of the behavioral performances before and after the neuromodulation by non-invasive cortical stimulation according to the age. More exactly, the investigators shall compare response times before and after neuromodulation between both age groups (18-49 years and 50-85 years), by testing the interaction between the effect of the neuromodulation and the age.

    Measured: 3 hours

Secondary outcomes (5)
  1. Estimate the effect of the neuromodulation on the behavioral performances

    Compare the percentages of correct answers before and after neuromodulation by non-invasive cortical electric stimulation, according to the age (18-49 years vs 50-85 years).

    Measured: 3 hours

  2. Estimate the effect of transcranial Electrical Stimulation (tES) on the cognitive performances by neuropsychological scores, according to the age.

    Comparison of the neuropsychological scores before and after tES, according to the age (18-49 years vs 50-85 years).

    Measured: 3 hours

  3. Estimate the effect of tES on the cerebral functional activity, by comparing blood-oxygen-level dependent (BOLD ) signal or functional MRI before and after tES according to the age (18-49 years vs 50-85 years).

    The investigators extract estimates parameters (Estimated Beta weight Values) corresponding to each tES stimulation. Each session is be designed by using general linear model (Friston, 1998, statistical parametrical mapping in fMRI) defined as Ybefore tES = R1Beta1+R2Beta2 +R0Beta0 + e and Yafter tES = R1Beta1 +R2Beta2 +R0Beta0 + e, with Y = acquired BOLD signal, e = error, R1Beta1 corresponding to the task (meaning interest activation) regressor and R2Beta2 corresponding to the control (meaning no interest activation) regressor respectively convolved with the canonical hemodynamic response function (cHRf) and R0B0 corresponding to the constant regressor. Parameter estimates are calculated by extracting Beta1 and Beta2 values for each session respectively in order to compute statistical comparison (measure by subject) on the outcome measure (Beta1 before tES - Beta1 after tES).

    Measured: 3 hours

  4. Estimate the effect of the Transcranial Magnetic Stimulation (TMS) on the cognitive performances by neuropsychological scores, according to the age.

    Comparison of the neuropsychological scores before and after Transcranial Magnetic Stimulation (TMS), according to the age (18-49 years vs 50-85 years).

    Measured: 3 hours

  5. Estimate the effect of the TMS on the intellectual functional activity, according to the age.

    Comparison of the cerebral functional activity (electric neuronal signal, EEG) before and after TMS, according to the age (18-49 years vs 50-85 years).

    Measured: 3 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 May 2017
  2. Study start31 Aug 2017
  3. Primary completionJun 2020 (estimated)
  4. Study completionJun 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Model description
outcoume measure comparison is done between both age groups (18-49 years and 50-85 years).
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03167931
Sponsor's protocol ID
38RC17.078
Other IDs
2017-A00834-49
Acronym
NEUROMOD
Status last verified
Jan 2019
First submitted
18 Apr 2017
Last updated
8 Jan 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Monti A, Ferrucci R, Fumagalli M, Mameli F, Cogiamanian F, Ardolino G, Priori A. Transcranial direct current stimulation (tDCS) and language. J Neurol Neurosurg Psychiatry. 2013 Aug;84(8):832-42. doi: 10.1136/jnnp-2012-302825. Epub 2012 Nov 8.

    PubMed 23138766
  • Liuzzi G, Freundlieb N, Ridder V, Hoppe J, Heise K, Zimerman M, Dobel C, Enriquez-Geppert S, Gerloff C, Zwitserlood P, Hummel FC. The involvement of the left motor cortex in learning of a novel action word lexicon. Curr Biol. 2010 Oct 12;20(19):1745-51. doi: 10.1016/j.cub.2010.08.034. Epub 2010 Sep 30.

    PubMed 20888226
  • Holland R, Leff AP, Josephs O, Galea JM, Desikan M, Price CJ, Rothwell JC, Crinion J. Speech facilitation by left inferior frontal cortex stimulation. Curr Biol. 2011 Aug 23;21(16):1403-7. doi: 10.1016/j.cub.2011.07.021. Epub 2011 Aug 4.

    PubMed 21820308
  • Rossi S, Hallett M, Rossini PM, Pascual-Leone A; Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009 Dec;120(12):2008-2039. doi: 10.1016/j.clinph.2009.08.016. Epub 2009 Oct 14.

    PubMed 19833552
  • Zimerman M, Hummel FC. Non-invasive brain stimulation: enhancing motor and cognitive functions in healthy old subjects. Front Aging Neurosci. 2010 Dec 1;2:149. doi: 10.3389/fnagi.2010.00149. eCollection 2010.

    PubMed 21151809

Questions about this trial

What is this clinical trial studying?

A study testing MRI + transcranial Magnetic Stimulation and transcranial electric stimulation + electroencephalogram in people with Healthy and Transcranial Magnetic Stimulation, run by University Hospital, Grenoble at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 16 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 8 Jan 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Thierry BOUGEROL (04 76 76 54 11, TBougerol@chu-grenoble.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Effect of the neuromodulation on the behavioral performances during the access in semantics (time frame: 3 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03167931, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jan 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in